# fNIRs-based Neurofeedback to Reduce Relapse in pOUD/AUD

> **NCT03595293** · NA · WITHDRAWN · sponsor: **Milton S. Hershey Medical Center**

## Conditions studied

- Alcohol Use Disorder
- Alcoholism
- Prescription Drug Dependence
- Opioid-use Disorder
- Neurofeedback

## Interventions

- **DEVICE:** fNIRs-based Neurofeedback
- **DEVICE:** Sham feedback

## Key facts

- **NCT ID:** NCT03595293
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-01-01
- **Primary completion:** 2027-02
- **Final completion:** 2028-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Covid-19 related delays made initiation of the project untenable
- **Last updated:** 2024-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03595293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03595293, "fNIRs-based Neurofeedback to Reduce Relapse in pOUD/AUD". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03595293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*